Hofseth BioCare ASA (HOFBF)
Hofseth BioCare ASA operates in the Biotechnology industry of the Consumer Defensive sector, headquartered in Ålesund, MR, NO. The stock last traded at $0.17, up 0.00% on the session, giving a market capitalisation of $68.5M. On trailing twelve-month figures it carries a trailing P/E of -3.83, a net margin of -56.9%. Its beta of 0.26 implies it has historically moved less than the broad market.
Hofseth BioCare ASA is a company specializing in the development and supply of premium, marine-derived ingredients for various applications in both human and animal health. Its market presence extends from Norway to an international scale. The company offers a diverse array of products. These include its general Brilliant salmon oil, alongside specialized formulations like OmeGo salmon oil, which is designed to support healthy cholesterol levels and cardiovascular function. ProGo, a rapidly absorbing salmon protein hydrolysate powder, serves as an efficient protein supplement. For bone and joint support, CalGo is a marine calcium powder developed to bolster cartilage function and promote overall joint health. Addressing beauty and wellness needs, CollaGo is a collagen peptide powder aimed at enhancing the strength and appearance of hair, skin, and nails. Rounding out their offerings is PetGo, a non-soluble protein for animal applications. Hofseth BioCare employs a multi-faceted distribution strategy, reaching customers through a network of independent distributors, agents, and its dedicated internal sales team. Furthermore, the firm maintains a significant research collaboration with the Stanford University School of Medicine. This partnership involves jointly conducting pre-clinical and clinical studies focused on conditions such as necrotizing enterocolitis and irritable bowel syndrome. Established in 2000, Hofseth BioCare ASA maintains its corporate headquarters in Ålesund, Norway.
Hofseth BioCare ASA is most often compared with the following Consumer Defensive names: